Data is not available at this time.
CNO Financial Group, Inc. operates as a holding company for a group of insurance subsidiaries, primarily serving middle-income pre-retiree and retired Americans through life, health, and annuity products. The company generates revenue through premiums, investment income, and fee-based services, with a focus on niche markets underserved by larger competitors. CNO’s market positioning is reinforced by its multi-channel distribution strategy, including independent agents, direct marketing, and worksite partnerships, allowing it to maintain a competitive edge in the middle-market segment. The company’s product portfolio includes Medicare supplements, long-term care insurance, and fixed-indexed annuities, catering to the financial security needs of an aging demographic. CNO’s disciplined underwriting and cost management practices further strengthen its ability to deliver consistent profitability in a highly regulated and competitive industry.
CNO reported revenue of $4.45 billion for the period, with net income of $404 million, reflecting a net margin of approximately 9.1%. Diluted EPS stood at $3.74, supported by strong premium growth and disciplined expense management. Operating cash flow was robust at $627.7 million, indicating efficient cash conversion from core operations. The absence of capital expenditures suggests a capital-light business model focused on underwriting and investment activities.
The company’s earnings power is driven by its ability to generate stable investment income and underwriting profits, with a focus on risk-adjusted returns. CNO’s capital efficiency is evident in its ability to maintain profitability while managing a diversified product mix. The diluted EPS of $3.74 underscores its capacity to deliver shareholder value through disciplined capital allocation and operational execution.
CNO’s balance sheet shows $1.66 billion in cash and equivalents, providing liquidity to meet policyholder obligations and strategic initiatives. Total debt of $4.52 billion reflects leverage used to support growth and investment activities. The company’s financial health is supported by its ability to generate consistent operating cash flow, ensuring stability in meeting debt obligations and funding dividends.
CNO has demonstrated steady growth in premiums and fee income, benefiting from demographic trends favoring retirement and health-related products. The company’s dividend policy, with a payout of $0.64 per share, reflects a commitment to returning capital to shareholders while retaining sufficient earnings for reinvestment. This balanced approach aligns with its long-term strategy of sustainable growth and shareholder returns.
The market values CNO based on its ability to deliver consistent earnings and cash flow in a competitive insurance landscape. Current metrics suggest investor confidence in its niche market focus and disciplined underwriting. The company’s valuation reflects expectations of stable growth, supported by its middle-market positioning and aging demographic tailwinds.
CNO’s strategic advantages include its targeted market focus, multi-channel distribution, and cost-efficient operations. The outlook remains positive, driven by demand for retirement and health insurance products among middle-income Americans. The company is well-positioned to capitalize on demographic trends, though regulatory and competitive pressures remain key considerations for sustained performance.
10-K, investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |